Author

Sophia Stock

German Cancer Research CenterORCID 0000-0002-5072-5013Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

Ignazio PisedduiD· 2 shared Sebastian KoboldiD· 2 shared Adrian GottschlichiD· 1 shared Adrien DaigeleriD· 1 shared Anand S. BhagwatiD· 1 shared Andreas ZinggiD· 1 shared Anne HoltermanniD· 1 shared Arman ÖneriD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Ignazio PisedduORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintOct 21, 2026

A CAR T cell-amplified suppressive B cell circuit in AML

Adrian Gottschlich, Vladyslav Kavaka, Thomas Alexander Janert…·Sebastian Kobold

The paper identifies suppressive atypical memory B cells in AML that are amplified by CAR T cell interactions and shows that targeting both B cells and AML blasts can overcome this suppression.

DOI 10.64898/2026.10.12.758644

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyNature CommunicationsPeer-reviewedFeb 2, 2024

Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia

Florian Märkl, Christoph Schultheiß, Murtaza Ali…·Mascha Binder

This study develops CAR T cells targeting a specific mutation in CLL to selectively kill cancer cells while sparing healthy B cells.

15 citations

humanproteomics

𝕏 PostBluesky